These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 17645151)
41. The Rise and Fall of the Liverpool Apothecaries Company 1836 to 1904. Anderson SA Pharm Hist (Lond); 2016 Mar; 46(1):17-22. PubMed ID: 29998721 [No Abstract] [Full Text] [Related]
42. Illustrations from the Wellcome Institute Library. Sequah: an English "American Medicine"-man in 1890. Schupbach W Med Hist; 1985 Jul; 29(3):272-317. PubMed ID: 3892198 [No Abstract] [Full Text] [Related]
43. Patent medicines for the treatment of genitourinary diseases. Rugendorff EW World J Urol; 1999 Jun; 17(3):171-5. PubMed ID: 10418092 [TBL] [Abstract][Full Text] [Related]
44. Remedies for a society's debilities. Medicines for neurasthenia in Victorian America. Stea J; Fried W N Y State J Med; 1993 Feb; 93(2):120-7. PubMed ID: 8455827 [No Abstract] [Full Text] [Related]
45. Relationships between the academic community and the pharmaceutical industry: the legislative background and its effect on spending on medical research and development. Matthews JH Clin Invest Med; 1996 Dec; 19(6):470-8. PubMed ID: 8959357 [TBL] [Abstract][Full Text] [Related]
46. Patent medicine. Kravetz RE Am J Gastroenterol; 2001 May; 96(5):1618. PubMed ID: 11374709 [No Abstract] [Full Text] [Related]
47. From plunger to Punkt-roller: a century of weight-loss quackery. Freedhoff Y CMAJ; 2009 Feb; 180(4):432-3. PubMed ID: 19221362 [No Abstract] [Full Text] [Related]
48. The unicorn and other lessons from history. Darby WJ Nutr Rev; 1974 Jul; 32(0):suppl 1:57-61. PubMed ID: 4845765 [No Abstract] [Full Text] [Related]
49. [3 contributions on the "Radioactive substances in therapy" topic, Praxis, 1932]. Praxis (Bern 1994); 2011 Nov; 100(24):1453-6. PubMed ID: 22124956 [No Abstract] [Full Text] [Related]
50. [On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation]. Maio G Dtsch Med Wochenschr; 2001 Oct; 126(42):1183-6. PubMed ID: 11607860 [No Abstract] [Full Text] [Related]
51. Profile: Jean Deleage. Ratner M Nat Biotechnol; 2005 Oct; 23(10):1197. PubMed ID: 16211047 [No Abstract] [Full Text] [Related]
52. Medicine show tonight. Oetting GD Ala J Med Sci; 1986 Apr; 23(2):212-6. PubMed ID: 3518517 [No Abstract] [Full Text] [Related]
53. The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals. Greene JA; Watkins ES N Engl J Med; 2015 Sep; 373(12):1087-9. PubMed ID: 26287749 [No Abstract] [Full Text] [Related]
55. Pharmaceutical patent life-cycle management after KSR v. Teleflex. Furrow ME Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462 [No Abstract] [Full Text] [Related]
56. Hocus pocus: a pharmacologic look at patent medicine colic cures. Waters MR Vet Herit; 1997 Nov; 20(2):40-4. PubMed ID: 11619753 [No Abstract] [Full Text] [Related]
57. Industry invites regulation: the passage of the Pure Food and Drug Act of 1906. Barkan ID Am J Public Health; 1985 Jan; 75(1):18-26. PubMed ID: 3881052 [TBL] [Abstract][Full Text] [Related]
58. [The Grains of health of Dr. Franck. From secret remedy to patent medicine]. Raynal C Rev Hist Pharm (Paris); 2008 Nov; 56(359):263-74. PubMed ID: 19230504 [TBL] [Abstract][Full Text] [Related]
59. [Medical journals supported by pharmaceutical industry: a more than one century history]. Bonnemain B Rev Hist Pharm (Paris); 2010 Jan; 57(364):399-416. PubMed ID: 20481381 [TBL] [Abstract][Full Text] [Related]